Review article: Biomedical intelligence THOMAS C. SAUTER, BALTHASAR EBERLE, WALTER A. WUILLEMIN, THOMAS THIELE, ANNE ANGELILLO-SCHERRER, ARISTOMENIS K. EXADAKTYLOS, GABOR ERDÖS, ADAM CUKER, MICHAEL NAGLER Management of anticoagulation-associated bleeding has become more challenging as the number of available drugs increases: vitamin K antagonists, unfractionated and low molecular heparin, as well as the newer direct oral anticoagulants targeting either factor Xa or thrombin. Original article SOENKE BOETTGER, DAVID GARCIA NUÑEZ, RAFAEL MEYER, ANDRE RICHTER, ALAIN RUDIGER, MARIA SCHUBERT, JOSEF JENEWEIN Several instruments have been developed to screen for and detect delirium, including the Intensive Care Delirium Screening Checklist (ICDSC). However, the optimal cut-off score indicating delirium is debated. RAPHAEL STEINER, ROBERT KRIDEL, EMILIANO GIOSTRA, THOMAS MCKEE, RITA ACHERMANN, NICOLAS MUELLER, ORIOL MANUEL, MICHAEL DICKENMANN, MACÉ M SCHUURMANS, LAURENCE DE LEVAL, THOMAS FEHR, MARIANNE TINGUELY, ISABELLE BINET, SERGIO COGLIATTI, EUGENIA HARALAMVIEVA, MICHAEL KOLLER, THE SWISS TRANSPLANT COHORT STUDY (STCS), PIERRE-YVES DIETRICH Post-transplant lymphoproliferative disorder (PTLD) is a potentially life-threatening complication of immunosuppression and oncogenic viral infections. JAKOB R. PASSWEG, HELEN BALDOMERO, MARC ANSARI, GABRIELA M. BAERLOCHER, MARIO BARGETZI, YVES CHALANDON, MICHEL A. DUCHOSAL, SABINE GERULL, TAYFUN GÜNGÖR, JÖRG P. HALTER, DOMINIK HEIM, URS HESS, KURT LEIBUNDGUT, STAVROULA MASOURIDI-LEVRAT, ANTONIA MÜLLER, GAYATHRI NAIR, THOMAS PABST, CHRISTOPH RENNER, ADRIAN SCHMIDT, GEORG STUSSI, GRAZIA NICOLOSO DE FAVERI, URS SCHANZ, FOR THE SWISS BLOOD STEM CELL TRANSPLANTATION GROUP (SBST) Federal regulations in Switzerland have made it mandatory to maintain a registry including all heamatopietic stem cell transplants performed in the country. Technical comment MATTHIAS EGGER, ANGELIKA KALT Author reply to Technical comment MICHAEL HAGNER |
No comments:
Post a Comment